87 related articles for article (PubMed ID: 23907903)
1. Cost-effectiveness of a cardiovascular disease primary prevention programme in a primary health care setting. Results of the Polish part of the EUROACTION project.
Sović N; Pająk A; Jankowski P; Duenas A; Kawecka-Jaszcz K; Wolfshaut-Wolak R; Stepaniak U; Kawalec P
Kardiol Pol; 2013; 71(7):702-11. PubMed ID: 23907903
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness and budget impact analysis of screening and preventive interventions for cardiovascular disease in Myanmar: an economic modelling study.
Win ZM; Mao W; Traill T; Kyaw ZL; Paing PY; Ogbuoji O; Yamey G
Lancet Reg Health Southeast Asia; 2024 Jul; 26():100394. PubMed ID: 38633709
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of a population-based AAA screening program for men over 65 years old in Iran.
Daroudi R; Shafe O; Moosavi J; Salimi J; Bayazidi Y; Zafarghandi MR; Maleki M; Moini M; Farshidmehr P; Sadeghipour P
Cost Eff Resour Alloc; 2021 May; 19(1):29. PubMed ID: 33985531
[TBL] [Abstract][Full Text] [Related]
4. Cost-Effectiveness Analysis of Screening for and Managing Identified Hypertension for Cardiovascular Disease Prevention in Vietnam.
Nguyen TP; Wright EP; Nguyen TT; Schuiling-Veninga CC; Bijlsma MJ; Nguyen TB; Postma MJ
PLoS One; 2016; 11(5):e0155699. PubMed ID: 27192051
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of Mediterranean diet and physical activity in secondary CVD prevention: results from the UCC-SMART cohort study.
Bonekamp NE; Visseren FLJ; van der Schouw YT; van der Meer MG; Teraa M; Ruigrok Y; Geleijnse JM; Koopal C;
Eur J Prev Cardiol; 2024 Mar; ():. PubMed ID: 38547043
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis.
Gaziano TA; Opie LH; Weinstein MC
Lancet; 2006 Aug; 368(9536):679-86. PubMed ID: 16920473
[TBL] [Abstract][Full Text] [Related]
7. Health and Economic Implications of National Treatment Coverage for Cardiovascular Disease in India: Cost-Effectiveness Analysis.
Basu S; Bendavid E; Sood N
Circ Cardiovasc Qual Outcomes; 2015 Nov; 8(6):541-51. PubMed ID: 26555122
[TBL] [Abstract][Full Text] [Related]
8. Long-term health outcomes and cost-effectiveness of a computer-tailored physical activity intervention among people aged over fifty: modelling the results of a randomized controlled trial.
Peels DA; Hoogenveen RR; Feenstra TL; Golsteijn RH; Bolman C; Mudde AN; Wendel-Vos GC; de Vries H; Lechner L
BMC Public Health; 2014 Oct; 14():1099. PubMed ID: 25342517
[TBL] [Abstract][Full Text] [Related]
9. Effect of including cancer mortality on the cost-effectiveness of aspirin for primary prevention in men.
Pignone M; Earnshaw S; McDade C; Pletcher MJ
J Gen Intern Med; 2013 Nov; 28(11):1483-91. PubMed ID: 23681842
[TBL] [Abstract][Full Text] [Related]
10. An economic analysis of usual care and acupuncture collaborative treatment on chronic low back pain: a Markov model decision analysis.
Kim N; Yang B; Lee T; Kwon S
BMC Complement Altern Med; 2010 Nov; 10():74. PubMed ID: 21106108
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness analysis of population-based tobacco control strategies in the prevention of cardiovascular diseases in Tanzania.
Ngalesoni F; Ruhago G; Mayige M; Oliveira TC; Robberstad B; Norheim OF; Higashi H
PLoS One; 2017; 12(8):e0182113. PubMed ID: 28767722
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness and budget impact of liraglutide in type 2 diabetes patients with elevated cardiovascular risk: a US-managed care perspective.
Shah D; Risebrough NA; Perdrizet J; Iyer NN; Gamble C; Dang-Tan T
Clinicoecon Outcomes Res; 2018; 10():791-803. PubMed ID: 30532570
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness evaluation of aspirin in primary prevention of myocardial infarction amongst males with average cardiovascular risk in Iran.
Amirsadri M; Sedighi MJ
Res Pharm Sci; 2017 Apr; 12(2):144-153. PubMed ID: 28515767
[TBL] [Abstract][Full Text] [Related]
14. The cost-effectiveness of a uniform versus age-based threshold for one-off screening for prevention of cardiovascular disease.
Špacírová Z; Kaptoge S; García-Mochón L; Rodríguez Barranco M; Sánchez Pérez MJ; Bondonno NP; Tjønneland A; Weiderpass E; Grioni S; Espín J; Sacerdote C; Schiborn C; Masala G; Colorado-Yohar SM; Kim L; Moons KGM; Engström G; Schulze MB; Bresson L; Moreno-Iribas C; Epstein D
Eur J Health Econ; 2023 Sep; 24(7):1033-1045. PubMed ID: 36239877
[TBL] [Abstract][Full Text] [Related]
15. Cost-Effectiveness of a Multicomponent Primary Care Intervention for Hypertension.
Chay J; Jafar TH; Su RJ; Shirore RM; Tan NC; Finkelstein EA
J Am Heart Assoc; 2024 Apr; 13(8):e033631. PubMed ID: 38606776
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of early intervention in psychosis in low- and middle-income countries: economic evaluation from São Paulo, Brazil.
Aceituno D; Razzouk D; Jin H; Pennington M; Gadelha A; Bressan R; Noto C; Crossley N; Prina M;
Epidemiol Psychiatr Sci; 2024 Apr; 33():e21. PubMed ID: 38576239
[TBL] [Abstract][Full Text] [Related]
17. A cost-effectiveness analysis of a community based CVD program in Sweden based on a retrospective register cohort.
Lindholm L; Stenling A; Norberg M; Stenlund H; Weinehall L
BMC Public Health; 2018 Apr; 18(1):452. PubMed ID: 29618323
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Cost-Effectiveness of Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in Adults With Type 1 Diabetes in Iran.
Molaee MC; Naseri ZG; Karami MA
Value Health Reg Issues; 2024 May; 43():101002. PubMed ID: 38820700
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and costs of treating uncomplicated stage 1 hypertension in primary care: a cross-sectional analysis.
Sheppard JP; Fletcher K; McManus RJ; Mant J
Br J Gen Pract; 2014 Oct; 64(627):e641-8. PubMed ID: 25267050
[TBL] [Abstract][Full Text] [Related]
20. Projected effect of dietary salt reductions on future cardiovascular disease.
Bibbins-Domingo K; Chertow GM; Coxson PG; Moran A; Lightwood JM; Pletcher MJ; Goldman L
N Engl J Med; 2010 Feb; 362(7):590-9. PubMed ID: 20089957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
